What is Applied Laboratories?
Founded in 1984, Applied Laboratories has transitioned from a specialized regulatory consultancy into a comprehensive contract development and manufacturing organization (CDMO). The company provides end-to-end support for pharmaceutical and healthcare clients, managing the complex lifecycle from initial formulation to final regulatory submission. Their core competency lies in the development of unique delivery systems for liquids and semi-solids, supported by robust quality control and innovative packaging solutions. By integrating research and development with commercial-scale production, Applied Laboratories serves as a critical partner for firms seeking to navigate the stringent requirements of the healthcare industry while maintaining flexible, responsive manufacturing schedules.
How much funding has Applied Laboratories raised?
Applied Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Applied Laboratories
PPP
Public-Private Partnership
What's next for Applied Laboratories?
With the successful acquisition of this late-stage capital, Applied Laboratories is poised to accelerate its growth trajectory by scaling its manufacturing capacity and deepening its R&D capabilities. The strategic focus will likely shift toward optimizing production efficiencies and expanding its footprint in the specialized delivery systems market. As the pharmaceutical industry continues to demand higher standards of regulatory compliance and supply chain agility, the company is strategically aligned to capture increased market share. Future initiatives will likely prioritize the integration of advanced manufacturing technologies and the enhancement of its service portfolio to meet the evolving needs of global healthcare partners, ensuring long-term sustainability and competitive advantage in the pharmaceutical manufacturing ecosystem.
See full Applied Laboratories company page
